United States: Brave New World: Compliance And The Transition To Value-Based Care

The U.S. health care system is in the midst of a fundamental shift, away from traditional "fee-for-service" models that reward providers for the quantity of services provided to patients, toward value-based models designed to reward the quality and efficiency of care provided to patients. This move to value-based care affects most sectors of the health care industry, including payors, providers, biopharma and medical device companies and other partner and support organizations, such as health information technology ("HIT") companies, population health management experts and other consultants. In order to effectively transition payment and care delivery systems, many of these organizations are rapidly developing, acquiring and partnering together to obtain the expertise necessary to participate in value-based care initiatives.

In a short time, value-based care initiatives have evolved from a set of initial programs sponsored by the Center for Medicare and Medicaid Innovation ("CMMI") to innovative payment and service delivery models that involve private payors and other entities bearing risk for the provision of health care services. With this evolution, providers and others have had to grapple with a regulatory framework that is not inherently well-suited to value-based payment arrangements. Further, traditional compliance programs are often not structured or prepared to manage the regulatory risks presented by new value-based initiatives. While the Secretary of Health and Human Services issued waivers of fraud and abuse laws applicable to CMMI initiative participants, no such waivers exist for commercial value-based care initiatives. As a result, companies seeking to create or participate in value-based care initiatives must be aware of potential regulatory challenges, and should structure both their compliance programs and the initiatives themselves to mitigate these risks. We discuss below key regulatory challenges and mitigation strategies for consideration during the transition to value-based care.

  • Anti-Kickback Statute. Fraud and abuse laws, and the Anti-Kickback Statute ("AKS") in particular, often present the greatest challenge when structuring value-based care arrangements. The AKS prohibits the knowing and willful solicitation, receipt, offer or payment of any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in return for either referrals of Federal health care program patients or the arranging, recommending, leasing or ordering of any item or service reimbursed by a Federal health care program. 1 Traditionally, providers, manufacturers and others have sought to structure arrangements to fit within one of the AKS safe harbors. This is often not possible with value-based care initiatives, in which some portion of the fees paid for services are "at risk" based upon a combination of cost savings, improved clinical quality, patient outcomes and/or patient satisfaction. In the absence of safe harbor protection, each value-based model is subject to a facts and circumstances analysis to determine whether the relevant sources of remuneration are intended to induce or reward referrals (and thus prohibited) or are intended solely to serve legitimate, "non-abusive" business interests (and thus permitted). 2 As a result, companies must carefully structure value-based arrangements to meet a facts and circumstances analysis—historically, by satisfying as many of the elements of an applicable AKS safe harbor as possible, with particular attention to ensuring the totality of the arrangement is at fair market value. Further, companies must implement safeguards sufficient to mitigate AKS risks posed by the risk-sharing portion of the value-based care initiative. There is limited sub-regulatory guidance available regarding the adequacy of safeguards in value-based care arrangements. Office of Inspector General ("OIG") Advisory Opinion 12-22, 3 which articulates OIG's position on risk-based arrangements outside of formalized CMS risk-sharing programs, highlights certain safeguards that may mitigate risk in value-based care arrangements. Such safeguards include, among other things, ensuring that: (i) cost-savings and quality measures are objective and verifiable, clearly and separately identified, and transparent; (ii) any risk-sharing program does not incentivize inappropriate reductions or limitations in services; and (iii) the organization conducts periodic reviews to protect against any inappropriate results, such as reductions or limitations in services. Though this 2013 Advisory Opinion provides helpful insight, many in the industry desire further guidance to ensure that the private sector has the ability to develop compliant value-based care arrangements.
  • Civil Monetary Penalties Law and Stark Law. The Civil Monetary Penalties ("CMP") Law and Stark Law may be implicated by value-based care arrangements, particularly those involving "gainsharing" initiatives (i.e., hospital-based efficiency initiatives under which hospitals pay physicians a share of cost reductions attributable to physicians' initiation and/or implementation of cost-savings measures), on the theory that such arrangements could lead to a reduction in the provision of medically necessary services to individuals and inappropriately reward referral of Federal health care program business. 4 The "Gainsharing CMP" prohibits hospitals from making, and physicians from receiving, direct or indirect payments as an "inducement to reduce or limit medically necessary services" to Medicare patients, 5 while the Stark Law prohibits a physician from referring Medicare beneficiaries for the furnishing of "designated health services," or DHS, to any entity with which the physician (or an immediate family member) has a financial relationship, unless the relationship meets the strict requirements of one or more of the exceptions enumerated in the statute or regulations. 6 Over time, government agencies such as OIG and Centers for Medicare and Medicaid Services ("CMS") have acknowledged that appropriately structured gainsharing arrangements may reduce hospital costs without causing inappropriate reductions in patient services or rewarding referrals of Federal health care program patients. 7 Though companies seeking to structure or utilize gainsharing components in value-based arrangements may see this as an opportunity, any such arrangement must still comply with the Gainsharing CMP and Stark Law, and should adhere as closely as possible to sub-regulatory guidance issued by OIG regarding gainsharing. The most useful guidance on gainsharing is derived from over a dozen OIG Advisory Opinions on gainsharing issued from 2000 to 2012. 8 As with OIG Advisory Opinion 12-22, these Advisory Opinions contain safeguards that may mitigate risk in gainsharing arrangements. Such safeguards include, among other things, utilizing objective historical and clinical measures to establish gainsharing arrangements, and ensuring that physicians have access to the same selection of items, supplies and devices as available before the gainsharing arrangement.
  • Data Sharing. Providers and payors are often "covered entities" under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), as amended, and are subject to privacy and security rules and requirements that limit their ability to share patient data with third parties. Other entities involved in value-based care initiatives (such as those performing data analysis, HIT or population management services) may be "business associates" under HIPAA subject to similar constraints regarding the use and disclosure of patient data. These constraints can be difficult to manage for any organization, but may prove onerous for organizations that also provide other health care products or services, particularly when such products or services may benefit from use of data collected when providing value-based care services.

    For example, a medical device company that acquires a population health management business may find itself in possession of patient data that it must protect in accordance with HIPAA. To do so, the medical device company typically must ensure that only those within the population health management business who require access to patient data receive such information, and ensure that the HIPAA-protected population health management business patient data does not become intermingled with the medical device business patient data. This requires careful initial structuring of the acquisition (e.g., considering whether to maintain the population health management organization as a separate legal entity), as well as ongoing training, auditing and monitoring to ensure that the population health management organization's patient data is maintained separately from data collected in the ordinary course by the device company business and cannot be accessed by the device company personnel. This situation may be further complicated by any shared services between the medical device and population health management businesses (e.g., information technology, human resources, billing) as well as the interest the sales force and others may have in intertwining the device and population health management businesses, despite restrictions established by HIPAA and other laws designed to protect the privacy and security of patient information.
  • Laws Regarding Risk Assumption. Some states have insurance regulations that may apply to entities that bear risk under value-based care arrangements. In addition, certain states have begun to regulate providers that accept financial risk under value-based care models and to scrutinize network development that consolidates health care markets in a way that impacts health care prices. Although payors are accustomed to compliance with insurance and similar regulations, many organizations that are not ordinarily classified as risk-bearing entities may be required to comply with these state laws. Compliance requirements would vary but may include, for example, adherence to a minimum capital requirement for the risk-sharing business.
  • Conflicts of Interest. With the expansion of value-based care, many organizations are providing, or seeking to provide, services outside their usual scope. While this necessarily requires an operational adjustment period, it also requires organizations to consider perceived or actual conflicts of interest in their traditional and new roles. For example, a post-acute care provider that manages a hospital palliative care department must consider how to manage the conflict of interest inherent in the manager's evaluation and recommendation of post-acute care providers to hospital patients.

The list above is not intended as an exhaustive survey of all applicable regulatory issues related to value-based care arrangements. The initiation and revision of any value-based care arrangement requires consideration of these and other potential regulatory hurdles, including those related to antitrust, corporate practice of medicine and fee-splitting laws, and tax issues.

Any organization seeking to implement value-based care initiatives should, as an initial matter, develop or advance its health care regulatory and compliance program to focus on risks inherent in value-based care arrangements. The organization's compliance department should be involved in the conception and structuring of any value-based care arrangement. The compliance department should focus on ensuring that, for each value-based arrangement, the company has established sufficient safeguards and has maintained documentation around the various components of the program. The compliance department should also monitor and audit each value-based care arrangement to ensure that it is continuing to operate consistent with applicable laws and legal guidance. An organization's effective development and deployment of its compliance program when structuring and monitoring value-based care initiatives will assist the organization in a smooth transition from a fee-for-service environment to one focused on value-based care.

Footnotes

1 42 U.S.C. § 1320a-7b(b).

2 Cf. generally 56 Fed. Reg. 35,952, 35,958 (July 29, 1991) (describing the statutory exceptions and AKS safe harbors as intended "to limit the reach of the statute somewhat by permitting certain non-abusive arrangements, while encouraging beneficial or innocuous arrangements").

OIG Advisory Opinion No. 12-22.

4 U.S. Government Accountability Office, Physician Incentive Payments by Hospitals Could Lead to Abuse, GAO/HRD-86-103 (July 1986), available at: http://www.gao.gov/assets/150/144561.pdf; OIG Special Advisory Bulletin, Gainsharing Arrangements and CMPs for Hospital Payments to Physicians to Reduce or Limit Services to Beneficiaries (July 1999), available at: https://oig.hhs.gov/fraud/docs/alertsandbulletins/gainsh.htm.

5 Soc. Sec. Act Sec. 1128A(b); Medicare Access and CHIP Reauthorization Act of 2015, Pub. L. No. 114-10 (2015).

6  See 42 U.S.C. § 1395nn(a)(1); 42 C.F.R. § 411.353.

7 See Testimony of Lewis Morris, Chief Counsel to the OIG (October 7, 2005), available at: https://oig.hhs.gov/testimony/docs/2005/Gainsharing10-07-05.pdf; series of favorable OIG advisory opinions issued between 1999 and 2012; changes to the Gainsharing CMP through the Medicare Access and CHIP Reauthorization Act of 2015 ("MACRA").

Gainsharing Arrangements and CMPs for Medical Center Payments to Physicians to Reduce or Limit Services to Beneficiaries" (July 1999); OIG Advisory Opinion No. 00-02 dated April 4, 2000; OIG Advisory Opinion No. 01-1 dated January 11, 2001; OIG Advisory Opinion No. 05-01 dated January 28, 2005; OIG Advisory Opinion No. 05-02 dated February 10, 2005; OIG Advisory Opinion No. 05-03 dated February 10, 2005; OIG Advisory Opinion No. 05-04 dated February 10, 2005; OIG Advisory Opinion No. 05-05 dated February 18, 2005; OIG Advisory Opinion No. 05-06 dated February 18, 2005; OIG Advisory Opinion No. 06-22 dated November 9, 2006; OIG Advisory Opinion No. 07-21 dated December 28, 2007; OIG Advisory Opinion No. 07-22 dated December 28, 2007; OIG Advisory Opinion No. 08-09 dated July 31, 2008; OIG Advisory Opinion No. 08-15 issued October 6, 2008; OIG Advisory Opinion No. 08-21 issued November 25, 2008; OIG Advisory Opinion No. 09-06.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions